tradingkey.logo

BUZZ-23andMe rises after special committee rejects CEO's buyback offer

ReutersMar 3, 2025 10:24 PM

Updates

Shares of DNA testing firm 23andMe ME.O rise 2% to $1.50 in extended trading

Special committee unanimously rejects CEO Anne Wojcicki's acquisition proposal

ME's CEO Anne Wojcicki had offered to buy the remaining stake in the company for $0.41/shr, or about $11 mln

Wojcicki said private equity firm New Mountain is no longer interested in acquiring ME

Last month, Wojcicki and New Mountain Capital had offered to take the company private for $2.53 per share, valuing the company at $67.9 million

As of last close, stock down 54.7% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI